AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...
Medical Device Network on MSN
AliveCor secures FDA approval for next-generation Kardia 12L ECG system
The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.
The ECG shows sinus tachycardia at about 115 beats per minute with a PR interval of about 0.15 sec (normal). The P waves show normal duration, but they are peaked in II, II and AVF and their amplitude ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果